Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
EFFECT
Notice of effectiveness
15 Apr 24
EFFECT
Notice of effectiveness
15 Apr 24
POS AM
Prospectus update (post-effective amendment)
11 Apr 24
POS AM
Prospectus update (post-effective amendment)
11 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
28 Mar 24
424B3
Prospectus supplement
26 Feb 24
424B3
Prospectus supplement
26 Feb 24
8-K
Other Events
23 Feb 24
424B3
Prospectus supplement
21 Feb 24
424B3
Prospectus supplement
21 Feb 24
8-K
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
20 Feb 24
424B3
Prospectus supplement
13 Feb 24
8-K
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
12 Feb 24
424B4
Prospectus supplement with pricing info
9 Feb 24
424B3
Prospectus supplement
8 Feb 24
EFFECT
Notice of effectiveness
8 Feb 24
8-K
Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study
8 Feb 24
424B3
Prospectus supplement
6 Feb 24
8-K
Other Events
6 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
S-1/A
IPO registration (amended)
2 Feb 24
S-1/A
IPO registration (amended)
1 Feb 24
CORRESP
Correspondence with SEC
1 Feb 24
424B3
Prospectus supplement
22 Jan 24
8-K
Other Events
19 Jan 24
424B3
Prospectus supplement
16 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12 Jan 24
424B3
Prospectus supplement
9 Jan 24
8-K
Tenax Therapeutics Announces Reverse Stock Split
5 Jan 24
UPLOAD
Letter from SEC
7 Dec 23
424B3
Prospectus supplement
1 Dec 23
S-1
IPO registration
1 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
1 Dec 23
424B3
Prospectus supplement
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
Latest ownership filings
SC 13G
S.H.N. Financial Investments Ltd.
20 Feb 24
SC 13G
CVI Investments, Inc.
16 Feb 24
SC 13G
Lind Global Fund II LP
15 Feb 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
3
LAWRENCE R HOFFMAN
12 Jan 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 23
SC 13G
INTRACOASTAL CAPITAL, LLC
13 Feb 23
SC 13D/A
Rich Stuart
9 Feb 23
SC 13D/A
Doogan Declan
9 Feb 23
SC 13D/A
Rich Stuart
6 Jan 23
SC 13D/A
Doogan Declan
6 Jan 23
SC 13D/A
Rich Stuart
23 Sep 22
4
Stuart Rich
23 Sep 22
SC 13D/A
Doogan Declan
12 Aug 22
4
Declan Doogan
12 Aug 22
SC 13G
ARMISTICE CAPITAL, LLC
21 Jun 22
SC 13D/A
ARMISTICE CAPITAL, LLC
17 Jun 22
4
Stuart Rich
10 Jun 22
4
GERALD T PROEHL
10 Jun 22
4
Robyn Hunter
10 Jun 22
4
Christopher Thomas Giordano
10 Jun 22
4
Declan Doogan
10 Jun 22
4
Michael H. Davidson
10 Jun 22
4
June Sherie Almenoff
10 Jun 22
SC 13D/A
ARMISTICE CAPITAL, LLC
20 May 22
4
Steven Boyd
19 May 22
3
June Sherie Almenoff
12 Apr 22
SC 13G/A
Hudson Bay Capital Management LP
4 Feb 22
3
Robyn Hunter
31 Jan 22
SC 13D/A
Rich Stuart
6 Dec 21
4
Stuart Rich
6 Dec 21
3
Eliot M Lurier
4 Nov 21
SC 13D/A
Doogan Declan
24 Aug 21
4
Declan Doogan
11 Aug 21
3
Chrisopher Thomas Giordano
15 Jul 21
4
Steven Boyd
9 Jul 21
SC 13D/A
ARMISTICE CAPITAL, LLC
9 Jul 21
4
Anthony A DiTonno
8 Jul 21
SC 13D
Doogan Declan
22 Jun 21
SC 13D
Rich Stuart
22 Jun 21